Sigyn Therapeutics (SIGY) EBITDA Margin (QoQ) (2017 - 2020)
Sigyn Therapeutics (SIGY) EBITDA Margin (QoQ) (2017 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -2.55 Mn |
| Dec 31, 2019 | 35,329.00 |
| Sep 30, 2019 | -22,482.00 |
| Jun 30, 2019 | 24,885.00 |
| Mar 31, 2019 | -2.41 Bn |
| Dec 31, 2018 | 2.41 Bn |
| Sep 30, 2018 | 376,682.00 |
| Jun 30, 2018 | -279,447.00 |
| Mar 31, 2018 | -129,846.00 |
| Dec 31, 2017 | 27,999.00 |
| Sep 30, 2017 | -8,441.00 |
| Jun 30, 2017 | -1,428.00 |